Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Robin L. Brey"'
Publikováno v:
Neurology. 96:483-490
This article provides an overview and update on the current status of academic neurology based on structured insights from departmental leaders across the United States. Academic neurology, at a time when and leaders in academic medicine in general,
Autor:
Jane A. Anderson, Sean I Savitz, Robin L. Brey, Steven Warach, Salvador Cruz-Flores, Mark P. Goldberg, James C. Grotta, Patricia D. Hurn, Thomas A. Kent
Publikováno v:
Stroke. 51:3778-3786
Autor:
Aron S. Buchman, Ana W. Capuano, Zoe Arvanitakis, Julie A. Schneider, Robin L. Brey, Steven R. Levine, Debra A. Fleischman, David A. Bennett, Konstantinos Arfanakis
Publikováno v:
Neuroepidemiology
Background: Few data are available on associations of antiphospholipid (aPL) antibodies with cognitive and motor decline in aging, and cerebrovascular disease on in vivo neuroimaging and postmortem neuropathology. Methods: This longitudinal, clinical
Publikováno v:
The ANTIPHOSPHOLIPID Syndrome ISBN: 9781351077125
The ANTIPHOSPHOLIPID Syndrome
The ANTIPHOSPHOLIPID Syndrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1427bdaa5d3b05f3a5c4ee283f543e7a
https://doi.org/10.1201/9781351077125-11
https://doi.org/10.1201/9781351077125-11
Autor:
Ralph L. Sacco, Stanley Tuhrim, Barbara C. Tilley, Steven R. Levine, Ann Catherin C Simpson, Robin L. Brey, Colum F. Amory, Mulugeta Gebregziabher, Jay P. Mohr
Publikováno v:
Cerebrovascular Diseases. 40:293-300
Background: There are very limited prospective data on the significance of persistent antiphospholipid antibodies (aPL) and recurrent thrombo-occlusive events (TOEs). We investigated the prognostic value of (1) 2 newer aPL assays, (2) an aPL portfoli
Autor:
Christopher DeFilippi, Robin L. Brey, Rebecca Gross, John L.P. Thompson, Robert H. Christenson, William T. Longstreth, David L. Tirschwell, Richard A. Kronmal, Stephen L. Seliger, Richard Buchsbaum, Steven R. Levine, Jay P. Mohr, Mitchell S.V. Elkind
Publikováno v:
Stroke. 44:714-719
Background and Purpose— Because of its association with atrial fibrillation and heart failure, we hypothesized that amino terminal pro–B-type natriuretic peptide (NT-proBNP) would identify a subgroup of patients from the Warfarin–Aspirin Recurr
Autor:
Christopher H. Topel, Vivek Misra, Réza Behrouz, Robin L. Brey, Ali Seifi, Mario Di Napoli, Lee A Birnbaum
Publikováno v:
Journal of neurovirology. 22(5)
Evidence for the association and the increased risk of stroke with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) is growing. Recent studies have reported on HIV infection as a potent risk factor for intracerebral hemorrha
Autor:
Julie A. Schneider, Aron S. Buchman, Steven R. Levine, Patricia A. Boyle, Lei Yu, Robin L. Brey, Zoe Arvanitakis, Sue Leurgans, David A. Bennett, Jacob H. Rand, Debra A. Fleischman, Konstantinos Arfanakis
Publikováno v:
Neuroepidemiology. 40:73-84
The overall goal of the Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging study is to test the hypothesis that antiphospholipid antibodies (aPL) are associated with an increased risk of pathologically proven brain
Autor:
Michael H. Weisman, Jorge Sanchez-Guerrero, Graciela S. Alarcón, Michelle Petri, Melissa Costner, Ann E. Clarke, Rosalind Ramsey-Goldman, Ronald F van Vollenhoven, Joseph L. Jorizzo, Søren Jacobsen, Daniel J. Wallace, Laurence S. Magder, Paul R. Fortin, Christine A. Peschken, Suhail Hameed, Robin L. Brey, Victoria P. Werth, Andrew G. Franks, Asad Zoma, Caroline Gordon, Peter J. Maddison, Guillermo Ruiz-Irastorza, Thomas Stoll, Sang Cheol Bae, Diane L. Kamen, Mary Anne Dooley, Sasha Bernatsky, David A. Isenberg, Gunnar Sturfelt, Anisur Rahman, S. Sam Lim, Barri J. Fessler, Joan T. Merrill, Dafna D. Gladman, Ana Maria Orbai, Gerald McGwin, Kenneth C. Kalunian, Kristjan Steinsson, Ngoc Minh Pham, Murray B. Urowitz, Murat Inanc, Munther A. Khamashta, Jill P. Buyon, Ellen M. Ginzler, Cynthia Aranow, John G. Hanly, Susan Manzi, Hong Fang, Ola Nived, Ian N. Bruce, Jeffrey P. Callen, Lisa Sigler
Publikováno v:
Arthritis & Rheumatism. 64:2677-2686
Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet st